News
Hyperfine (Nasdaq:HYPR) enrolled the initial patients in a study of its portable MRI technology for neurological evaluation.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback